Literature DB >> 11566943

Intrarenal transport and vasoactive substances in hypertension.

P A Ortiz1, J L Garvin.   

Abstract

Blood pressure is influenced by several vasoactive factors that also regulate nephron transport. An imbalance in regulation of salt reabsorption by the nephron contributes to hypertension. In the spontaneously hypertensive rat (SHR), the responses to dopamine and angiotensin II in the proximal nephron are diminished and enhanced, respectively. This partially explains why the proximal tubule of SHR absorbs more salt and water than that of normotensive controls. In the Dahl salt-sensitive rat, defects in NO signaling and alterations in the arachidonic acid/cytochrome P450 pathways are associated with increased salt reabsorption by the thick ascending limb. In other animal models, such as the deoxycorticosterone acetate (DOCA)-salt rat, hypertension develops as the result of an induced hormonal imbalance. By mimicking the effects of aldosterone, DOCA stimulates sodium reabsorption in the collecting ducts, causing salt and fluid retention. Thus, this model is similar to inherited forms of human hypertension caused by abnormal regulation of transport by mineralocorticoids, such as apparent mineralocorticoid excess and glucocorticoid-remediable aldosteronism. Overall, these findings demonstrate the significance of vasoactive compounds in regulating nephron transport and controlling blood pressure. However, important questions regarding humoral control of nephron transport and its implications in hypertension remain unanswered, and intensive research in these areas is required.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566943     DOI: 10.1161/hy09t1.093361

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  23 in total

1.  Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Authors:  Ken Chen; Kun Deng; Xiaoyan Wang; Zhen Wang; Shuo Zheng; Hongmei Ren; Duofen He; Yu Han; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

Review 2.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

Review 3.  Musculoskeletal aspects of hypoadrenalism: just a load of aches and pains?

Authors:  N Sathi; D Makkuni; W S Mitchell; D Swinson; C Chattopadhyay
Journal:  Clin Rheumatol       Date:  2009-03-06       Impact factor: 2.980

4.  Renal and endocrine changes in rats with inherited stress-induced arterial hypertension (ISIAH).

Authors:  Sergej Amstislavsky; Pia Welker; Jan-Henning Frühauf; Larissa Maslova; Ludmila Ivanova; Boye Jensen; Arkady L Markel; Sebastian Bachmann
Journal:  Histochem Cell Biol       Date:  2005-12-08       Impact factor: 4.304

Review 5.  Dopamine receptor-coupling defect in hypertension.

Authors:  Pedro A Jose; Gilbert M Eisner; Robin A Felder
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

6.  A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.

Authors:  John J Gildea; Dylan T Lahiff; Robert E Van Sciver; Ryan S Weiss; Neema Shah; Helen E McGrath; Cynthia D Schoeffel; Pedro A Jose; Robert M Carey; Robin A Felder
Journal:  Clin Chim Acta       Date:  2013-02-27       Impact factor: 3.786

7.  D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.

Authors:  Quansheng Lu; Yu Yang; Van Anthony Villar; Laureano Asico; John E Jones; Peiying Yu; Hewang Li; Edward J Weinman; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertens Res       Date:  2013-02-21       Impact factor: 3.872

Review 8.  The Renal Sodium Bicarbonate Cotransporter NBCe2: Is It a Major Contributor to Sodium and pH Homeostasis?

Authors:  Robin A Felder; Pedro A Jose; Peng Xu; John J Gildea
Journal:  Curr Hypertens Rep       Date:  2016-09       Impact factor: 5.369

9.  Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.

Authors:  Yiqiang Zhou; Pengcheng Luo; Hsin-Hsin Chang; Hui Huang; Tianxin Yang; Zheng Dong; Cong-Yi Wang; Mong-Heng Wang
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

10.  Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney.

Authors:  Donald R Dunbar; Hiba Khaled; Louise C Evans; Emad A S Al-Dujaili; Linda J Mullins; John J Mullins; Christopher J Kenyon; Matthew A Bailey
Journal:  Physiol Genomics       Date:  2009-11-17       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.